MISSION & VISION
MISSION
Enable faster access to functional proteins
Our mission is to enable researchers and innovators to access functional proteins more quickly, with fewer technical barriers and improved reproducibility, so that science can progress at the speed it deserves.
VISION
A world without expression bottlenecks
We envision a future where protein expression is no longer a limitation to scientific discovery and biomedical innovation, where any researcher can produce any protein reliably in just a few days.
SCIENTIFIC ORIGINS
Academic foundation
University of Cambridge
The ProteoY platform was developed from research conducted within the Department of Biochemistry at the University of Cambridge, one of the world’s leading centers in cell biology and protein science.
ProteoY technology originates from academic work carried out in Cambridge, where the need for a more reliable protein expression system emerged from real experimental challenges.
This research led to the development of a yeast expression platform based on a self-selection principle, later translated into the ProteoY solution.
Experimental challenge identified
During research on cell cycle regulation, existing expression systems repeatedly failed to reliably produce functional protein complexes.
Development of the self-selection principle
A fundamentally new approach using essential gene deletion to ensure plasmid stability without selection pressure.
Peer-reviewed publications
Methodology validated and published in Gene (2007) and Methods in Molecular Biology (2009).
Commercial platform
An academic innovation transformed into a robust and accessible protein expression service available to researchers worldwide.
The people behind ProteoY
A complementary duo combining deep academic expertise and industrial execution, the combination required to transform a research platform into a scalable technology.
Marco Geymonat
⚗️ Co-founder & CTO
Professor & researcher · University of Cambridge
Dr. Marco Geymonat is a recognized researcher and professor at the University of Cambridge, specializing in cell polarity, spindle orientation, and cell cycle progression in yeast.
With over 15 years of experience, his work focuses on the fundamental mechanisms of cell division, conserved from yeast to humans. His research has major implications for understanding genetic stability and preventing diseases such as cancer.
Alongside his academic work, he has contributed to several innovative projects, including patents related to protein expression technologies. He has notably contributed to the development of advanced selection markers for heterologous protein expression.
His work is widely recognized in the field of genetics, and he continues to contribute to both fundamental research and biotechnological applications.
Samuel Guesne
🏭 Co-founder & CEO
Graduate Engineer · Systems & Industrial Engineering
Samuel Guesne is an engineer specialized in electronics and applied physics. He began his career at National Instruments, where he developed strong expertise over five years.
He then led a systems engineering department, managing a team of fifteen multidisciplinary engineers working on complex systems in the automotive and aerospace sectors.
Since 2020, he has been leading Gemesis, une entreprise innovante spécialisée dans la conception de systèmes automatisés de test et de production, ainsi que dans le développement logiciel pour les secteurs de l’énergie, du transport et du biomédical.
Sous sa direction, Gemesis an innovative company specialized in automated test and production systems, as well as software development for energy, transport, and biomedical sectors.
Under his leadership, Gemesis has developed unique expertise in designing automated components requiring precise control of physical phenomena.
Samuel Guesne is recognized for his leadership and his ability to manage complex technical projects while delivering innovative solutions tailored to client needs.
PARTNERS & ECOSYSTEM
ProteoY operates within a scientific and industrial ecosystem including academic institutions, research collaborators, and technology partners.
We actively develop partnerships with research teams, biotechnology companies, and CROs seeking to integrate a reliable protein expression solution into their workflows.
WHAT WE STAND FOR
Our values
🔬Scientific rigor
Every claim is based on published and reproducible results. We do not rely on opaque systems.
⚡Speed with integrity
Fast results should never compromise quality. We believe both are possible, and ProteoY demonstrates this.
🤝Researcher-first approach
We exist to serve researchers whose work depends on reliable access to functional proteins. Their success is our benchmark.
🔁Continuous improvement
Science evolves, and so do we. We are committed to continuous development and fostering collaborations to advance the platform.
Interested in collaborating or learning more about ProteoY?
We would be pleased to learn about your project and explore how ProteoY can support your research or development goals.